Over the past 15 years, treatment options for ulcerative colitis (UC) have expanded quite a bit. Among the most common options is a class of drugs called biologics. Biologics are derived from natural ...
Vedolizumab as a first-line biologic in UC offers cost savings and clinical benefits, improving QALYs compared to TNF-α inhibitors. In CD, vedolizumab provides incremental benefits but incurs higher ...
Biologics are complex medications produced through biological processes or from living organisms such as proteins and genes. Biosimilars are what they sound like — similar to, but not the same as, an ...
2025 NOV 18 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- Data detailed on Biotechnology - Biologics have been presented. According to news originating from New York City, ...
Pharma At Its Best: Quicker. Better. Nicer. Given the dramatic changes in GLP-1 and biologic treatments and their rapid adoption, real-world data illuminating patient feedback and prescriber rationale ...
Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...
SKYRIZI ® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) for inflammatory bowel diseases, initially for Crohn’s ...
Spyre Therapeutics is emerging as a key player in inflammatory bowel disease, with a focus on pathway-specific monoclonal antibodies for superior disease control. The company has a healthy balance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback